iifl-logo

Most Read News

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Download App
image

Infosys on 10 March 2022 has allotted 805891 equity shares pursuant to the exercise of Restricted Stock Units by eligible employees as hereunder 494632 equity shares under the 2015 Stock Incentive Compensation Plan; 310449 equity shares under the Infosys Expanded Stock Ownership Program 2019

image

Mishra Dhatu Nigam announced that the Board of Directors of the Company at its meeting held on 14 March 2022 inter alia have recommended the interim dividend of Rs 156 per equity Share ie 156Percentage subject to the approval of the shareholders

image

The Board of Sobha at its meeting held on 14 March 2022 has approved the resignation of Jagdish Chandra Sharma as Director and Vice Chairman and-Managing Director with effect from 01 April 2022 The Board also approved the appointment of Jagadish Nangineni as an Additional Director in the capacity of Whole-time Director designated as Managing Director and Key Managerial Personnel of the Company for a […]

image

Strides Pharma Science announced that an Extra Ordinary General Meeting EGM of the Company will be held on 7 April 2022

image

The Board of Black Box at its meeting held on 14 March 2022 has approved the proposal for Sub division Split of Equity Shares of the Company from face value of Rs 10 each into Equity Shares of face value of Re 2 each subject to the approval of the members of the Company through the ensuing postal ballot

image

Alembic Pharmaceuticals today announced that it has received tentative approval from the US Food Drug Administration USFDA for its Abbreviated New Drug Application ANDA for Macitentan Tablets 10 mg The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product RLD Opsumit Tablets 10 mg of Actelion Pharmaceuticals US Inc Actelion Macitentan Tablets are an endothelin receptor antagonist ERA indicated for the treatment […]

image

Ducon Infratechnologies will hold a meeting of the Board of Directors of the Company on 22 March 2022

image

Tasty Dairy Specialities announced that Ashok Kumar Tripathi DIN No08363248 has resigned from the board of the company on 12 March 2022

image

ISMT announced that the company has remitted the full and final settlement amount towards the outstanding debt of the Company to the respective Lenders Authorized Dealers

image

Hexa Tradex will hold a meeting of the Board of Directors of the Company on 21 March 2022

Image
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.